Vestmark Advisory Solutions, Inc. Gilead Sciences, Inc. Transaction History

Vestmark Advisory Solutions, Inc.

$2.43 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$76.01 - $86.7 $188,124 - $214,582	-2,475 Reduced 14.54%	14,552 $1.12 Million
Q1 2023 May 09, 2023	SELL	$77.31 - $88.08 $229,456 - $261,421	-2,968 Reduced 14.84%	17,027 $1.41 Million
Q4 2022 Jan 20, 2023	BUY	$62.32 - $89.47 $55,901 - $80,254	897 Added 4.7%	19,995 $0
Q3 2022 Nov 03, 2022	SELL	$59.54 - $68.01 $82,046 - $93,717	-1,378 Reduced 6.73%	19,098 $1.18 Million
Q2 2022 Aug 04, 2022	BUY	$57.72 - $65.01 $26,839 - $30,229	465 Added 2.32%	20,476 $1.27 Million
Q1 2022 Apr 27, 2022	BUY	$57.92 - $72.58 $53,981 - $67,644	932 Added 4.88%	20,011 $1.19 Million
Q4 2021 Jan 31, 2022	SELL	$64.88 - $73.64 $454 - $515	-7 Reduced 0.04%	19,079 $1.39 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $484,660 - $522,894	7,160 Added 60.04%	19,086 $1.33 Million
Q2 2021 Aug 09, 2021	SELL	$63.47 - $69.35 $634 - $693	-10 Reduced 0.08%	11,926 $821,000
Q1 2021 May 10, 2021	BUY	$60.0 - $68.46 $33,360 - $38,063	556 Added 4.89%	11,936 $771,000
Q4 2020 Feb 04, 2021	SELL	$56.65 - $64.55 $30,874 - $35,179	-545 Reduced 4.57%	11,380 $663,000
Q3 2020 Oct 19, 2020	BUY	$62.1 - $78.08 $15,214 - $19,129	245 Added 2.1%	11,925 $754,000
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $337,249 - $391,608	-4,662 Reduced 28.53%	11,680 $899,000
Q1 2020 May 06, 2020	SELL	$62.63 - $80.22 $303,129 - $388,264	-4,840 Reduced 22.85%	16,342 $1.22 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $14,727 - $16,199	-239 Reduced 1.12%	21,182 $1.38 Million
Q3 2019 Nov 05, 2019	BUY	$62.51 - $69.0 $292,671 - $323,058	4,682 Added 27.97%	21,421 $1.36 Million
Q2 2019 Aug 20, 2019	BUY	$61.87 - $69.38 $513,397 - $575,715	8,298 Added 98.31%	16,739 $1.13 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $527,815 - $591,292	8,441 New	8,441 $549,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.

Account